|
|
|
|
|
|
|
|
|
|
ClinicalTrials.gov
Purpose
This
study is being done to create a registry to help us learn more about
urinary and other cancers. This will let us look at large groups of
people who do and do not have this kind of cancer.
The investigators will
look at risk factors to learn more about how these impact cancer. The
investigators will also look at genetic markers. These are genes that
are found in a known place. They are often associated with a particular
trait. If the gene changes in some way, it may predict cancer or
response to treatment. The investigators will look for markers in your
saliva.
This registry will help us develop better methods of:
Preventing these cancers. Diagnosing these cancers. Treating these cancers.
| Condition | Intervention |
|---|---|
|
Urothelial Cancer Renal Pelvis Cancer Ureter Cancer Bladder Cancer |
Other: saliva sample and questionaire Other: saliva sample, questionaire |
| Study Type: | Observational | ||||||||||
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
||||||||||
| Official Title: | Familial and Atypical Urothelial Cancer Registry | Eligibility
Study Population
A
member of the patient's treatment team, the protocol investigator, or a
member of the research team at Memorial Sloan-Kettering Cancer Center
(MSKCC) will identify potential research subjects. At MSKCC the
following outpatient clinics will be used to recruit UC cases: Urology
and Genitourinary Oncology. Patients and families may also be directly
referred to the study team by any MSKCC physician, external physician,
or by the family itself.
Criteria
Inclusion Criteria:
Urothelial Cancer Cases
|
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.